PRA Health Sciences Inc (PRAH, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. PRA Health Sciences Inc is a United State based full-service global contract research organization. It provides a broad range of product development services for pharmaceutical and biotechnology companies around the world. PRA Health Sciences Inc has a market cap of $6.77 billion; its shares were traded at around $107.09 with a P/E ratio of 29.73 and P/S ratio of 2.39. PRA Health Sciences Inc had annual average EBITDA growth of 54.50% over the past five years.
For the last quarter PRA Health Sciences Inc reported a revenue of $780.7 million, compared with the revenue of $717.6 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $3.1 billion, an increase of 6.8% from last year. For the complete 30-year financial data, please go here.. For the last five years PRA Health Sciences Inc had an average revenue growth rate of 17.6% a year.
The reported diluted earnings per share was $3.68 for the year, an increase of 58.6% from previous year. The PRA Health Sciences Inc had a decent operating margin of 11.9%, compared with the operating margin of 9.8% a year before. The 10-year historical median operating margin of PRA Health Sciences Inc is 7.82%. The profitability rank of the company is 6 (out of 10).
At the end of the fiscal year, PRA Health Sciences Inc has the cash and cash equivalents of $236.2 million, compared with $144.2 million in the previous year. The long term debt was $1.3 billion, compared with $1.1 billion in the previous year. PRA Health Sciences Inc has a financial strength rank of 4 (out of 10).
At the current stock price of $107.09, PRA Health Sciences Inc is traded at close to its historical median P/S valuation band of $97.61. The P/S ratio of the stock is 2.39, while the historical median P/S ratio is 2.17. The stock lost 4.38% during the past 12 months.
For the complete 20-year historical financial data of PRAH, click here.
